OC METRO CALENDAR

  • February 2012
    SuMoTuWeThFrSa
    2930311234
    567891011
    12131415161718
    19202122232425
    26272829123
    45678910
Add an event

MEDICAL TECHNOLOGY
Untitled Page

Agendia raises $23 million in series E financing

The Huntington Beach-based medical technology company also presented at UBS Global Life Sciences Conference on Wednesday. 

By Susan BelknappPublished: September 23, 2009 10:45 AM

Huntington Beach and Amsterdam-based Agendia, a global leader in molecular cancer diagnostics, announced Wednesday the successful closing of a US $23 million series E investment. The financing was led by an undisclosed family investment firm that provided approximately half of the funds.

Two independent entrepreneurs also committed to an investment of $1 million each. The remaining capital was raised through Agendia’s existing investor base.

“The success of this financing round was aided by MammaPrint’s increasing U.S. demand, as well as growing reimbursement from private U.S. payors," says Dr. Bernhard Sixt, president and CEO of Agendia. "The proceeds will be used to accelerate the commercialization of MammaPrint in the U.S. market.” 


Dr. Sixt presented at the UBS Global Life Sciences Conference on Wednesday, September 23 at the Grand Hyatt hotel in New York.

NEXT PAGE >>

Related headlines
West Coast University expands to North Hollywood
Chapman report: Economic Forecast for the Legal Profession
UC Irvine nets $320,000 to expand free online initiative
Irvine’s Spectrum Pharmaceuticals raises $50 million
Orange County loses more than 6,000 jobs over the month